miR-544a induces epithelial–mesenchymal transition through the activation of WNT signaling pathway in gastric cancer

Carcinogenesis

Volumn 36, Issue 11, 2015, Pages 1363-1371

  Yanaka, Yoshimitsu ^a,b   Muramatsu, Tomoki ^a   Uetake, Hiroyuki ^b   Kozaki, Ken Ichi ^a,b,c   Inazawa, Johji ^a,b  

^a Tokyo Scientific Research Institute   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR; MESSENGER RNA; MICRORNA; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN; AXIN; AXIN2 PROTEIN, HUMAN; CADHERIN; CDH1 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; HOMEODOMAIN PROTEIN; MIRN544 MICRORNA, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; ZEB1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER GROWTH; CANCER SCREENING; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL MOTILITY; CELL SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSIS; FLUORESCENCE INTENSITY; GASTRIC CANCER CELL LINE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LUCIFERASE ASSAY; METASTASIS; MKN1 CELL LINE; MKN28 CELL LINE; OPTICAL DENSITY; PHENOTYPE; PHENOTYPIC PLASTICITY; PLASMID; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; RNA EXTRACTION; STOMACH CANCER; TRANSWELL ASSAY; WESTERN BLOTTING; WNT SIGNALING; WOUND HEALING; ACTIVE TRANSPORT; BINDING SITE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROTEIN STABILITY; STOMACH TUMOR; TUMOR CELL LINE; WNT SIGNALING PATHWAY;

ACTIVE TRANSPORT, CELL NUCLEUS; AXIN PROTEIN; BASE SEQUENCE; BETA CATENIN; BINDING SITES; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MICRORNAS; PROTEIN STABILITY; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY;

EID: 84984537201     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv106     Document Type: Article

References (28)

1. Ferlay, J. et al. (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer, 136, E359–E386.
2. Matsuda, A. et al.; Japan Cancer Surveillance Research Group. (2014) Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn. J. Clin. Oncol., 44, 388–396.
3. Yang, J. et al. (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell, 14, 818–829.
4. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2, 442–454.
5. Bryant, D.M. et al. (2008) From cells to organs: building polarized tissue. Nat. Rev. Mol. Cell Biol., 9, 887–901.
6. Thiery, J.P. et al. (2009) Epithelial-mesenchymal transitions in development and disease. Cell, 139, 871–890.
7. Tam, W.L. et al. (2013) The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat. Med., 19, 1438–1449.
8. Lamouille, S. et al. (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol., 15, 178–196.
9. Berx, G. et al. (2009) Involvement of members of the cadherin super-family in cancer. Cold Spring Harb. Perspect. Biol., 1, a003129.
10. Cullen, B.R. (2004) Transcription and processing of human microRNA precursors. Mol. Cell, 16, 861–865.
11. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281–297.
12. Lujambio, A. et al. (2012) The microcosmos of cancer. Nature, 482, 347–355.
13. Esquela-Kerscher, A. et al. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259–269.
14. Kozaki, K. et al. (2012) Tumor-suppressive microRNA silenced by tumor-specific DNA hypermethylation in cancer cells. Cancer Sci., 103, 837–845.
15. Xu, J. et al. (2009) TGF-beta-induced epithelial to mesenchymal transition. Cell Res., 19, 156–172.
16. Harazono, Y. et al. (2013) miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS One, 8, e62757.
17. Yamamoto, S. et al. (2014) The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors. Mol. Cancer Res., 12, 58–68.
18. Uesugi, A. et al. (2011) The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res., 71, 5765–5778.
19. Tsuruta, T. et al. (2011) miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res., 71, 6450–6462.
20. Takada, H. et al. (2005) Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Sci., 96, 100–110.
21. Imoto, I. et al. (2001) Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. Cancer Res., 61, 6629–6634.
22. Kozaki, K. et al. (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res., 68, 2094–2105.
23. Rittling, S.R. et al. (1987) Functional analysis and growth factor regulation of the human vimentin promoter. Mol. Cell. Biol., 7, 3908–3915.
24. Mo, X. et al. (2014) miR-544a promotes the invasion of lung cancer cells by targeting cadherina 1 in vitro. Onco. Targets. Ther., 7, 895–900.
25. Mo, X.M. et al. (2014) Downregulation of GSK3β by miR-544a to maintain self-renewal ability of lung caner stem cells. Oncol. Lett., 8, 1731–1734.
26. Jho, E.H. et al. (2002) Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol. Cell. Biol., 22, 1172–1183.
27. Nelson, W.J. et al. (2004) Convergence of Wnt, beta-catenin, and cadherin pathways. Science, 303, 1483–1487.
28. Polakis, P. (2000) Wnt signaling and cancer. Genes Dev., 14, 1837–1851.